Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SynOss is a synthetic bone grafting material developed by Collagen Matrix, primarily used in dental and orthopedic procedures to repair or reconstruct bony and periodontal defects. It is a calcium phosphate-based osteoconductive material with an apatite structure that mimics human bone, providing a scaffold for new bone formation. SynOss is available in multiple forms, including granules and a putty formulation, the latter being a mineral-collagen composite that becomes moldable upon hydration. It is indicated for clinical applications such as filling extraction sockets, alveolar ridge augmentation, and maxillary sinus floor elevation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on SynOss.